Purchase
Description
STELARA® (Ustekinumab) is a human IgG1κ monoclonal antibody against the p40 subunit of the IL-12 and IL-23 cytokines. Using DNA recombinant technology, ustekinumab is produced in a well characterized recombinant cell line and is purified using standard bio-processing technology. The manufacturing process contains steps for the clearance of viruses. Ustekinumab is comprised of 1326 amino acids and has an estimated molecular mass that ranges from 148,079 to 149,690 Daltons.
Ustekinumab is a sterile, preservative-free, colorless to light yellow solution and may contain a few small translucent or white particles with pH of 5.7- 6.3. Ustekinumab is supplied at a concentration of 5 mg/mL, which contains 0.02 mg/mL EDTA disodium salt dihydrate, 0.77 mg/mL L-histidine, 1.04 mg/mL L-histidine hydrochloride monohydrate, 0.4 mg/mL L-methionine, 0.4 mg/mL Polysorbate 80 and 85 mg/mL sucrose.
Properties
|
Name
|
Ustekinumab
|
|
CAS
NO.
|
815610-63-0
|
|
Type
|
Whole antibody
|
|
Source
|
Human
|
|
Target
|
IL-12 and
IL-23
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
148 kDa
|
|
Formula
|
C6482H10004N1712O2016S46
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Place
of Origin
|
China (Mainland)
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180531095387488748.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Ustekinumab
|
